Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including >3.32 million people tested with real-time PCR and >219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United States
View ORCID ProfileAsieh Golozar, View ORCID ProfileLana YH Lai, View ORCID ProfileAnthony G. Sena, View ORCID ProfileDavid Vizcaya, View ORCID ProfileLisa M. Schilling, View ORCID ProfileVojtech Huser, View ORCID ProfileFredrik Nyberg, View ORCID ProfileScott L. Duvall, Daniel R. Morales, View ORCID ProfileThamir M Alshammari, View ORCID ProfileHamed Abedtash, Waheed-Ul-Rahman Ahmed, View ORCID ProfileOsaid Alser, View ORCID ProfileHeba Alghoul, Ying Zhang, Mengchun Gong, Yin Guan, View ORCID ProfileCarlos Areia, View ORCID ProfileJitendra Jonnagaddala, View ORCID ProfileKarishma Shah, Jennifer C.E. Lane, Albert Prats-Uribe, Jose D. Posada, Nigam H. Shah, Vignesh Subbian, Lin Zhang, Maria Tereza Fernandes Abrahão, View ORCID ProfilePeter R. Rijnbeek, Seng Chan You, Paula Casajust, View ORCID ProfileElena Roel, View ORCID ProfileMartina Recalde, Sergio Fernández-Bertolín, Alan Andryc, Jason A. Thomas, View ORCID ProfileAdam B. Wilcox, Stephen Fortin, View ORCID ProfileClair Blacketer, View ORCID ProfileFrank DeFalco, Karthik Natarajan, View ORCID ProfileThomas Falconer, Matthew Spotnitz, View ORCID ProfileAnna Ostropolets, View ORCID ProfileGeorge Hripcsak, View ORCID ProfileMarc Suchard, Kristine E. Lynch, View ORCID ProfileMichael E. Matheny, Andrew Williams, View ORCID ProfileChristian Reich, View ORCID ProfileTalita Duarte-Salles, View ORCID ProfileKristin Kostka, Patrick B. Ryan, View ORCID ProfileDaniel Prieto-Alhambra
doi: https://doi.org/10.1101/2020.10.25.20218875
Asieh Golozar
1Regeneron Pharmaceutical, NY USA
2Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, MD USA
Lana YH Lai
3Division of Cancer Sciences, School of Medical Sciences, University of Manchester, UK
Anthony G. Sena
4Janssen R&D, Titusville NJ, USA
5Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
David Vizcaya
6Bayer Pharmaceuticals, Sant Joan Despi, Spain
Lisa M. Schilling
7Data Science to Patient Value Program, University of Colorado Anschutz Medical Campus
Vojtech Huser
8National Library of Medicine, National Institutes of Health, Bethesda, MD, USA
Fredrik Nyberg
9School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Scott L. Duvall
10VINCI, VA Salt Lake City Health Care System, Salt Lake City, VA, & Division of Epidemiology, University of Utah, Salt Lake City, UT
Daniel R. Morales
11Division of Population Health and Genomics, University of Dundee, UK
Thamir M Alshammari
12Medication Safety Research Chair, King Saud University, Riyadh, Saudi Arabia
Hamed Abedtash
13Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN
Waheed-Ul-Rahman Ahmed
14Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
15College of Medicine and Health, University of Exeter, St Luke’s Campus, Heavitree Road, Exeter, EX1 2LU, UK
Osaid Alser
16Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
Heba Alghoul
17Faculty of Medicine, Islamic University of Gaza, Palestine
Ying Zhang
18DHC Technologies Co. Ltd, Beijing, China
Mengchun Gong
18DHC Technologies Co. Ltd, Beijing, China
Yin Guan
18DHC Technologies Co. Ltd, Beijing, China
Carlos Areia
19Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK
Jitendra Jonnagaddala
20School of Public Health and Community Medicine, UNSW Sydney, Australia
Karishma Shah
14Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
Jennifer C.E. Lane
14Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
Albert Prats-Uribe
14Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
Jose D. Posada
21Stanford University School of Medicine, Stanford, California, USA
Nigam H. Shah
21Stanford University School of Medicine, Stanford, California, USA
Vignesh Subbian
22College of Engineering, The University of Arizona, Tucson, Arizona, USA
Lin Zhang
23School of Population Medicine and Public Health, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China
24Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
Maria Tereza Fernandes Abrahão
24Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
Peter R. Rijnbeek
5Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
Seng Chan You
26Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, South Korea
Paula Casajust
27Real-World Evidence, Trial Form Support, Barcelona, Spain
Elena Roel
28Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
Martina Recalde
28Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
29Universitat Autònoma de Barcelona, Spain
Sergio Fernández-Bertolín
28Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
Alan Andryc
4Janssen R&D, Titusville NJ, USA
Jason A. Thomas
30Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, WA, USA
Adam B. Wilcox
30Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, WA, USA
31UW Medicine, Seattle, WA, USA
Stephen Fortin
32Observational Health Data Analytics, Janssen Research and Development, Raritan, NJ, USA
Clair Blacketer
4Janssen R&D, Titusville NJ, USA
5Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
Frank DeFalco
4Janssen R&D, Titusville NJ, USA
Karthik Natarajan
33Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY 10032, USA
34New York-Presbyterian Hospital, 622 W 168 St, PH20 New York, NY 10032 USA
Thomas Falconer
33Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY 10032, USA
Matthew Spotnitz
33Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY 10032, USA
Anna Ostropolets
33Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY 10032, USA
George Hripcsak
33Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY 10032, USA
34New York-Presbyterian Hospital, 622 W 168 St, PH20 New York, NY 10032 USA
Marc Suchard
35Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, USA
Kristine E. Lynch
10VINCI, VA Salt Lake City Health Care System, Salt Lake City, VA, & Division of Epidemiology, University of Utah, Salt Lake City, UT
Michael E. Matheny
36VINCI, Tennessee Valley Healthcare System VA, Nashville, TN & Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN
Andrew Williams
37Tufts Institute for Clinical Research and Health Policy Studies, US
Christian Reich
38Real World Solutions, IQVIA, Cambridge, MA, USA
Talita Duarte-Salles
28Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
Kristin Kostka
38Real World Solutions, IQVIA, Cambridge, MA, USA
Patrick B. Ryan
4Janssen R&D, Titusville NJ, USA
5Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
Daniel Prieto-Alhambra
39Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, UK
Data Availability
Analyses were performed locally in compliance with all applicable data privacy laws. Although the underlying data is not readily available to be shared, authors contributing to this paper have direct access to the data sources used in this study. All results (e.g. aggregate statistics, not presented at a patient-level with redactions for minimum cell count) are available for public inquiry. These results are inclusive of site-identifiers by contributing data sources to enable interrogation of each contributing site. All analytic code and result sets are made available at: https://github.com/ohdsi-studies/Covid19CharacterizationCharybdis
https://github.com/ohdsi-studies/Covid19CharacterizationCharybdis
Posted October 27, 2020.
Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including >3.32 million people tested with real-time PCR and >219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United States
Asieh Golozar, Lana YH Lai, Anthony G. Sena, David Vizcaya, Lisa M. Schilling, Vojtech Huser, Fredrik Nyberg, Scott L. Duvall, Daniel R. Morales, Thamir M Alshammari, Hamed Abedtash, Waheed-Ul-Rahman Ahmed, Osaid Alser, Heba Alghoul, Ying Zhang, Mengchun Gong, Yin Guan, Carlos Areia, Jitendra Jonnagaddala, Karishma Shah, Jennifer C.E. Lane, Albert Prats-Uribe, Jose D. Posada, Nigam H. Shah, Vignesh Subbian, Lin Zhang, Maria Tereza Fernandes Abrahão, Peter R. Rijnbeek, Seng Chan You, Paula Casajust, Elena Roel, Martina Recalde, Sergio Fernández-Bertolín, Alan Andryc, Jason A. Thomas, Adam B. Wilcox, Stephen Fortin, Clair Blacketer, Frank DeFalco, Karthik Natarajan, Thomas Falconer, Matthew Spotnitz, Anna Ostropolets, George Hripcsak, Marc Suchard, Kristine E. Lynch, Michael E. Matheny, Andrew Williams, Christian Reich, Talita Duarte-Salles, Kristin Kostka, Patrick B. Ryan, Daniel Prieto-Alhambra
medRxiv 2020.10.25.20218875; doi: https://doi.org/10.1101/2020.10.25.20218875
Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including >3.32 million people tested with real-time PCR and >219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United States
Asieh Golozar, Lana YH Lai, Anthony G. Sena, David Vizcaya, Lisa M. Schilling, Vojtech Huser, Fredrik Nyberg, Scott L. Duvall, Daniel R. Morales, Thamir M Alshammari, Hamed Abedtash, Waheed-Ul-Rahman Ahmed, Osaid Alser, Heba Alghoul, Ying Zhang, Mengchun Gong, Yin Guan, Carlos Areia, Jitendra Jonnagaddala, Karishma Shah, Jennifer C.E. Lane, Albert Prats-Uribe, Jose D. Posada, Nigam H. Shah, Vignesh Subbian, Lin Zhang, Maria Tereza Fernandes Abrahão, Peter R. Rijnbeek, Seng Chan You, Paula Casajust, Elena Roel, Martina Recalde, Sergio Fernández-Bertolín, Alan Andryc, Jason A. Thomas, Adam B. Wilcox, Stephen Fortin, Clair Blacketer, Frank DeFalco, Karthik Natarajan, Thomas Falconer, Matthew Spotnitz, Anna Ostropolets, George Hripcsak, Marc Suchard, Kristine E. Lynch, Michael E. Matheny, Andrew Williams, Christian Reich, Talita Duarte-Salles, Kristin Kostka, Patrick B. Ryan, Daniel Prieto-Alhambra
medRxiv 2020.10.25.20218875; doi: https://doi.org/10.1101/2020.10.25.20218875
Subject Area
Subject Areas
- Addiction Medicine (400)
- Allergy and Immunology (711)
- Anesthesia (202)
- Cardiovascular Medicine (2954)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12764)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4598)
- Geriatric Medicine (420)
- Health Economics (730)
- Health Informatics (2934)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (925)
- Medical Education (427)
- Medical Ethics (116)
- Nephrology (470)
- Neurology (4373)
- Nursing (237)
- Nutrition (640)
- Oncology (2277)
- Ophthalmology (647)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1197)
- Primary Care Research (499)
- Public and Global Health (6963)
- Radiology and Imaging (1532)
- Respiratory Medicine (915)
- Rheumatology (440)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (181)